Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Microbiome Medicine Center, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Front Cell Infect Microbiol. 2019 Feb 4;9:4. doi: 10.3389/fcimb.2019.00004. eCollection 2019.
Gut microbiota is a newly identified risk factor for stroke, and there are no large prospective studies linking the baseline gut microbiome to long-term risk of stroke. We present here the correlation between the gut microbiota and stroke risk in people with no prior stroke history. A total of 141 participants aged ≥60 years without prior history of stroke were recruited and divided into low-risk, medium-risk, and high-risk groups based on known risk factors and whether they were suffering from chronic diseases. The composition of their gut microbiomes was compared using 16S rRNA gene amplicon next-generation-sequencing and Quantitative Insights into Microbial Ecology (QIIME) analysis. Levels of fecal short-chain fatty acids were measured using gas chromatography. We found that opportunistic pathogens (e.g., Enterobacteriaceae and Veillonellaceae) and lactate-producing bacteria (e.g., and ) were enriched, while butyrate-producing bacteria (e.g., Lachnospiraceae and Ruminococcaceae) were depleted, in the high-risk group compared to the low-risk group. Butyrate concentrations were also lower in the fecal samples obtained from the high-risk group than from the low-risk group. The concentrations of other short-chain fatty acids (e.g., acetate, propionate, isobutyrate, isovalerate, and valerate) in the gut were comparable among the three groups. Participants at high risk of stroke were characterized by the enrichment of opportunistic pathogens, low abundance of butyrate-producing bacteria, and reduced concentrations of fecal butyrate. More researches into the gut microbiota as a risk factor in stroke should be carried out in the near future.
肠道微生物群是新发现的中风危险因素,但目前尚无大型前瞻性研究将基线肠道微生物群与中风的长期风险联系起来。我们在此介绍了无既往中风史人群的肠道微生物群与中风风险之间的相关性。
共招募了 141 名年龄≥60 岁、无既往中风史的参与者,根据已知的危险因素和是否患有慢性病,将他们分为低危组、中危组和高危组。使用 16S rRNA 基因扩增子下一代测序和定量微生物生态分析(QIIME)分析比较了他们的肠道微生物群组成。使用气相色谱法测量粪便短链脂肪酸水平。
我们发现,与低危组相比,高危组中机会性病原体(例如肠杆菌科和韦荣氏球菌科)和产乳酸细菌(例如 和 )富集,而丁酸产生菌(例如lachnospiraceae 和 ruminococcaceae)减少。高危组粪便样本中的丁酸浓度也低于低危组。三组间其他短链脂肪酸(如乙酸、丙酸、异丁酸、异戊酸和戊酸)的浓度无差异。
中风高危人群的特征是机会性病原体富集、丁酸产生菌丰度低、粪便丁酸浓度降低。未来应开展更多关于肠道微生物群作为中风危险因素的研究。